Novo Nordisk, the Danish manufacturer of obesity drugs Ozempic and Wegovy, is planning to build a 'mega manufacturing facility' outside of Dublin, creating up to 1,100 jobs. The company's market cap has been reduced, affecting the TAM. Silicon Valley is showing interest in Ozempic, likening it to Vyvanse. There are predictions about the impact of Semaglutides on the market in 2025.
2025 Prediction: Semaglutides are gonna create a bunch of super nits and blasters who choose to abstain from Ozempic will run the streets https://t.co/MHphbf5fyp
$NVO | Novo Nordisk, Maker Of 'Miracle' Weight Loss Drug Ozempic, Announces Mega Factory In Dublin https://t.co/nx6knmvULP
OZEMPIC MAKER SET TO BUILD MEGA FACTORY IN DUBLIN Novo Nordisk $NVO the Danish manufacturer of obesity drugs Ozempic and Wegovy, is planning a “mega manufacturing facility” outside of Dublin Novo has applied to build a campus in Clondalkin which would create up to 1,100 jobs in… https://t.co/NDHo0CLHhj
The company behind blockbuster obesity drugs Ozempic and Wegovy is reportedly planning a “mega manufacturing facility” outside of Dublin https://t.co/5bxTr9WofX
Silicon valley really trying to make ozempic the next vyvanse innit
Ozempic market cap reduced by 1/52nd which shaves…. a hundred billion from the TAM 😂 https://t.co/ctuSiZNDjn